Peng Li
- Molecular Biology top 2%
- Cancer Research top 2%
- Oncology top 5%
- Plant Science top 5%
- Surgery top 10%
- Topics
- Metabolomics and Mass Spectrometry Studies (13 papers)Analytical Chemistry and Chromatography (13 papers)MicroRNA in disease regulation (12 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Peng Li
183 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Molecular Biology 3.5k
- Cancer Research 739
- Oncology 677
- Plant Science 595
- Surgery 494
Countries citing papers authored by Peng Li
This map shows the geographic impact of Peng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Li more than expected).
Fields of papers citing papers by Peng Li
This network shows the impact of papers produced by Peng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Li. The network helps show where Peng Li may publish in the future.
Co-authorship network of co-authors of Peng Li
This figure shows the co-authorship network connecting the top 25 collaborators of Peng Li. A scholar is included among the top collaborators of Peng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Li. Peng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 17 | |
| 9 | 7 | |
| 10 | 0 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 40 | |
| 14 | 17 | |
| 15 | 24 | |
| 16 | 10 | |
| 17 | 19 | |
| 18 | An Investigation into Traditional Chinese Medicine Hospitals in China: Development Trend and Medical Service Innovation | 0 |
| 19 | 15 | |
| 20 | 25 |
About Peng Li
Peng Li is a scholar working on Pharmacology, Cancer Research and Complementary and alternative medicine, having authored 195 papers that have together received 6.4k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (13 papers), Analytical Chemistry and Chromatography (13 papers) and MicroRNA in disease regulation (12 papers). The work is most often cited by research in Complementary and alternative medicine (491 citations), Pharmacology (460 citations) and Molecular Biology (3.5k citations). Peng Li has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Jian‐Bo Wan, Chengwei He, Hu Y, Huanxing Su, Peter P. Roller, Renxiao Wang, Xueliang Fang, York Tomita, Zaneta Nikolovska‐Coleska and Shaomeng Wang. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.